Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

1.

The Ashkenazi Jewish carrier screening panel: evolution, status quo, and disparities.

Hoffman JD, Park JJ, Schreiber-Agus N, Kornreich R, Tanner AK, Keiles S, Friedman KJ, Heim RA.

Prenat Diagn. 2014 Dec;34(12):1161-7. doi: 10.1002/pd.4446. Epub 2014 Jul 31.

PMID:
24996053
[PubMed - in process]
2.

Cognitive and Antipsychotic Medication Use in Monoallelic GBA-Related Parkinson Disease.

Barrett MJ, Shanker VL, Severt WL, Raymond D, Gross SJ, Schreiber-Agus N, Kornreich R, Ozelius LJ, Bressman SB, Saunders-Pullman R.

JIMD Rep. 2014;16:31-8. doi: 10.1007/8904_2014_315. Epub 2014 May 22.

PMID:
24850235
[PubMed]
Free PMC Article
3.

Carrier testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze.

Ferreira JC, Schreiber-Agus N, Carter SM, Klugman S, Gregg AR, Gross SJ.

Am J Obstet Gynecol. 2014 Sep;211(3):197-204. doi: 10.1016/j.ajog.2014.02.001. Epub 2014 Feb 5. Review.

PMID:
24508465
[PubMed - indexed for MEDLINE]
4.

Detection of carriers in the Ashkenazi Jewish population: an objective comparison of high-throughput genotyping versus gene-by-gene testing.

Klugman S, Schreiber-Agus N, Nazareth S, Evans EA.

Genet Test Mol Biomarkers. 2013 Oct;17(10):763-7. doi: 10.1089/gtmb.2013.0105. Epub 2013 Aug 17.

PMID:
23952016
[PubMed - indexed for MEDLINE]
5.

The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease.

Gan-Or Z, Ozelius LJ, Bar-Shira A, Saunders-Pullman R, Mirelman A, Kornreich R, Gana-Weisz M, Raymond D, Rozenkrantz L, Deik A, Gurevich T, Gross SJ, Schreiber-Agus N, Giladi N, Bressman SB, Orr-Urtreger A.

Neurology. 2013 Apr 23;80(17):1606-10. doi: 10.1212/WNL.0b013e31828f180e. Epub 2013 Mar 27.

PMID:
23535491
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Platelet hexosaminidase a enzyme assay effectively detects carriers missed by targeted DNA mutation analysis.

Nakagawa S, Zhan J, Sun W, Ferreira JC, Keiles S, Hambuch T, Kammesheidt A, Mark BL, Schneider A, Gross S, Schreiber-Agus N.

JIMD Rep. 2012;6:1-6. doi: 10.1007/8904_2011_120. Epub 2012 Jan 31.

PMID:
23430931
[PubMed]
Free PMC Article
7.

Transcranial sonography and functional imaging in glucocerebrosidase mutation Parkinson disease.

Barrett MJ, Hagenah J, Dhawan V, Peng S, Stanley K, Raymond D, Deik A, Gross SJ, Schreiber-Agus N, Mirelman A, Marder K, Ozelius LJ, Eidelberg D, Bressman SB, Saunders-Pullman R; LRRK2 Ashkenazi Jewish Consortium.

Parkinsonism Relat Disord. 2013 Feb;19(2):186-91. doi: 10.1016/j.parkreldis.2012.09.007. Epub 2012 Oct 10.

PMID:
23062841
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Rapid and novel prenatal molecular assay for detecting aneuploidies and microdeletion syndromes.

Gross SJ, Bajaj K, Garry D, Klugman S, Karpel BM, Roe AM, Wagner BJ, Zhan J, Apfelroth SD, Schreiber-Agus N.

Prenat Diagn. 2011 Mar;31(3):259-66. doi: 10.1002/pd.2674. Epub 2011 Jan 4.

PMID:
21207408
[PubMed - indexed for MEDLINE]
9.

Population-based Tay-Sachs screening among Ashkenazi Jewish young adults in the 21st century: Hexosaminidase A enzyme assay is essential for accurate testing.

Schneider A, Nakagawa S, Keep R, Dorsainville D, Charrow J, Aleck K, Hoffman J, Minkoff S, Finegold D, Sun W, Spencer A, Lebow J, Zhan J, Apfelroth S, Schreiber-Agus N, Gross S.

Am J Med Genet A. 2009 Nov;149A(11):2444-7. doi: 10.1002/ajmg.a.33085.

PMID:
19876898
[PubMed - indexed for MEDLINE]
10.

Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines.

Lopes EC, Valls E, Figueroa ME, Mazur A, Meng FG, Chiosis G, Laird PW, Schreiber-Agus N, Greally JM, Prokhortchouk E, Melnick A.

Cancer Res. 2008 Sep 15;68(18):7258-63. doi: 10.1158/0008-5472.CAN-08-0344.

PMID:
18794111
[PubMed - indexed for MEDLINE]
Free Article
11.

Rybp interacts with Hippi and enhances Hippi-mediated apoptosis.

Stanton SE, Blanck JK, Locker J, Schreiber-Agus N.

Apoptosis. 2007 Dec;12(12):2197-206.

PMID:
17874297
[PubMed - indexed for MEDLINE]
12.

Differential effects of Mxi1-SRalpha and Mxi1-SRbeta in Myc antagonism.

Dugast-Darzacq C, Grange T, Schreiber-Agus NB.

FEBS J. 2007 Sep;274(17):4643-53. Epub 2007 Aug 14.

PMID:
17697116
[PubMed - indexed for MEDLINE]
13.

Rybp, a polycomb complex-associated protein, is required for mouse eye development.

Pirity MK, Wang WL, Wolf LV, Tamm ER, Schreiber-Agus N, Cvekl A.

BMC Dev Biol. 2007 Apr 30;7:39.

PMID:
17470285
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The Polycomb-associated protein Rybp is a ubiquitin binding protein.

Arrigoni R, Alam SL, Wamstad JA, Bardwell VJ, Sundquist WI, Schreiber-Agus N.

FEBS Lett. 2006 Nov 13;580(26):6233-41. Epub 2006 Oct 19. Erratum in: FEBS Lett. 2006 Dec 11;580(28-29):6754.

PMID:
17070805
[PubMed - indexed for MEDLINE]
Free Article
15.

Yaf2 inhibits caspase 8-mediated apoptosis and regulates cell survival during zebrafish embryogenesis.

Stanton SE, McReynolds LJ, Evans T, Schreiber-Agus N.

J Biol Chem. 2006 Sep 29;281(39):28782-93. Epub 2006 Aug 4.

PMID:
16891308
[PubMed - indexed for MEDLINE]
Free Article
16.

Lessons learned from Myc/Max/Mad knockout mice.

Pirity M, Blanck JK, Schreiber-Agus N.

Curr Top Microbiol Immunol. 2006;302:205-34. Review.

PMID:
16620030
[PubMed - indexed for MEDLINE]
17.

Rybp/DEDAF is required for early postimplantation and for central nervous system development.

Pirity MK, Locker J, Schreiber-Agus N.

Mol Cell Biol. 2005 Aug;25(16):7193-202.

PMID:
16055728
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Mxi1-SRalpha: a novel Mxi1 isoform with enhanced transcriptional repression potential.

Dugast-Darzacq C, Pirity M, Blanck JK, Scherl A, Schreiber-Agus N.

Oncogene. 2004 Nov 25;23(55):8887-99.

PMID:
15467743
[PubMed - indexed for MEDLINE]
19.

Prostatic intraepithelial neoplasia and intestinal metaplasia in prostates of probasin-RAS transgenic mice.

Scherl A, Li JF, Cardiff RD, Schreiber-Agus N.

Prostate. 2004 Jun 1;59(4):448-59.

PMID:
15065094
[PubMed - indexed for MEDLINE]
20.

Evidence that Myc isoforms transcriptionally repress caveolin-1 gene expression via an INR-dependent mechanism.

Park DS, Razani B, Lasorella A, Schreiber-Agus N, Pestell RG, Iavarone A, Lisanti MP.

Biochemistry. 2001 Mar 20;40(11):3354-62.

PMID:
11258956
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk